TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23204096

Group type: COMPARATOR
Intervention: 35 percent calcium-free (CF) hydrogen peroxide gel
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 35 percent calcium-containing (CC) hydrogen peroxide gel
Number of subjects: 40
Study: 20843153

Group type: EXPERIMENTAL
Intervention: Vitamin A at 200,000 IU per day
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 18307921

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide sealer (Sealapex)
Number of subjects: 100

Group type: COMPARATOR
Intervention: ZOE sealer
Number of subjects: 100
Study: 16199742

Group type: EXPERIMENTAL
Intervention: Blind smears
Number of subjects: 151

Group type: COMPARATOR
Intervention: Guided smears
Number of subjects: 151
Study: 14524141

Group type: EXPERIMENTAL
Intervention: Emotion-oriented care intervention
Number of subjects: 151

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 151
Study: 11214781

Group type: EXPERIMENTAL
Intervention: Glibenclamide (2.5 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Glipizide (2.5 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8878758

Group type: EXPERIMENTAL
Intervention: Antithymocyte induction (5 of 37 patients)
Number of subjects: 152

Group type: COMPARATOR
Intervention: No antithymocyte induction (5 of 115 patients)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: More than two episodes of rejection during the first year after heart transplantation
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Trimethoprim/sulfamethoxazole treatment
Number of subjects: 152
Study: 1436435

Group type: EXPERIMENTAL
Intervention: Object velocity (four different velocities)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control experiment with varying object velocity and size
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Fixed location for grasping with varying object velocity
Number of subjects: 6
Study: 6496208

Group type: EXPERIMENTAL
Intervention: Breath holding duration of 20 seconds
Number of subjects: 0

Group type: COMPARATOR
Intervention: Breath holding duration of less than 20 seconds
Number of subjects: 0
Study: 30933599

Group type: EXPERIMENTAL
Intervention: Fruit and vegetable vouchers only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weekly vouchers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unrestricted vouchers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monthly vouchers
Number of subjects: 0
Study: 27831697

Group type: EXPERIMENTAL
Intervention: Therapeutic alliance
Number of subjects: 59
Study: 25857366

Group type: EXPERIMENTAL
Intervention: Silymarin 420 mg daily in three divided doses starting 24‐48 h before cisplatin infusion and continuing through three 21‐day cisplatin chemotherapy courses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25110226

Group type: EXPERIMENTAL
Intervention: Low-glucose PD regimen (dextrose-based PD solution plus icodextrin and amino acids)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Conventional PD regimen (dextrose PD solutions)
Number of subjects: 251
Study: 22479156

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: 24 weeks of cART
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: 60 weeks of cART
Number of subjects: 173
Study: 19008494

Group type: EXPERIMENTAL
Intervention: Low-fat meal (approximately 530 kcal; 100 g of carbohydrate, 1 g of fat, and 30 g of protein)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control meal (approximately 800 kcal; 100 g of carbohydrate, 31 g of fat, and 30 g of protein)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Low-fat meal plus lipid infusion (same meal as low-fat meal, total energy 800 kcal, with approximately 30 g fat via intravenous lipid infusion)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Low-fat meal
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control meal
Number of subjects: 9
Study: 17595937

Group type: EXPERIMENTAL
Intervention: Caudal ketamine 0.5 mg/kg diluted with 0.9% saline
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Caudal ketamine mixed with 0.125% bupivacaine 1 ml/kg
Number of subjects: 62

Group type: COMPARATOR
Intervention: Plain 0.125% bupivacaine 1 ml/kg
Number of subjects: 62
Study: 14998831

Group type: EXPERIMENTAL
Intervention: Coping Skills Training
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Group Support
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Information
Number of subjects: 39
Study: 11588451

Group type: EXPERIMENTAL
Intervention: Gastric feeding with erythromycin (200 mg iv every 8 hrs)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Transpyloric feeding
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Gastric feeding with erythromycin
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Gastric feeding with erythromycin and Transpyloric feeding
Number of subjects: 80
Study: 9661589

Group type: EXPERIMENTAL
Intervention: Estradiol levels from 10-25 pg/mL
Number of subjects: 274

Group type: COMPARATOR
Intervention: Estradiol levels below 5 pg/mL
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Estradiol levels exceeding 5 pg/mL
Number of subjects: 274
Study: 8005183

Group type: EXPERIMENTAL
Intervention: 1 mg iv infusion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 5 mg oral solution
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 5 mg standard tablet
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 10 mg slow release formulation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2523957

Group type: EXPERIMENTAL
Intervention: GR 38032F, 0.18 mg/kg, every six or every eight hours for three doses, beginning 30 minutes before cisplatin
Number of subjects: 85
Study: 596252

Group type: EXPERIMENTAL
Intervention: Penicillin and streptomycin
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Cephalosporin and gentamycin
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Cephalosporin and gentamycin with semi-isolation and granulocyte transfusions
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Intestinal sterilization with systemic antibiotics
Number of subjects: 67
Study: 31285348

Group type: EXPERIMENTAL
Intervention: Giving motivational advice to younger students
Number of subjects: 1982

Group type: COMPARATOR
Intervention: Control condition (no advice given)
Number of subjects: 1982
Study: 29064406

Group type: EXPERIMENTAL
Intervention: Diosgenin-rich yam extract for 12 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 26140415

Group type: EXPERIMENTAL
Intervention: Açai functional beverage (AB)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (without AB)
Number of subjects: 14
Study: 25380005

Group type: EXPERIMENTAL
Intervention: Stimulation of the efferent limb of the ileostomy before surgery
Number of subjects: 70

Group type: COMPARATOR
Intervention: Nonstimulation before surgery
Number of subjects: 70
Study: 22456329

Group type: COMPARATOR
Intervention: TACE
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: TACE-V (endostatin 15mg/m2 intravenously after TACE)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: TACE-A (endostatin 15mg/m2 through hepatic artery during TACE)
Number of subjects: 95

Group type: COMPARATOR
Intervention: non-TACE
Number of subjects: 95
Study: 19017893

Group type: EXPERIMENTAL
Intervention: Supervised asthma therapy
Number of subjects: 290
Study: 17200487

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GPI-1485
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (from DATATOP study)
Number of subjects: 0
Study: 16462710

Group type: EXPERIMENTAL
Intervention: Acarbose therapy
Number of subjects: 5

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 5
Study: 11455971

Group type: EXPERIMENTAL
Intervention: Regimen A: 12 intensive parenteral treatments of intermediate dose (1 g/m2 each) methotrexate (MTX) and mercaptopurine (MP) over 24 weeks.
Number of subjects: 490

Group type: COMPARATOR
Intervention: Regimen B: 12 intensive courses of alternating myelosuppressive drug combinations over 30 weeks, including MTX/MP, teniposide (VM-26)/cytosine arabinoside (AC), and VCR/PDN/DNR/AC/ASP.
Number of subjects: 490
Study: 9724685

Group type: EXPERIMENTAL
Intervention: G‐6‐PD‐deficient neonates with hyperbilirubinemia
Number of subjects: 2

Group type: COMPARATOR
Intervention: G‐6‐PD‐deficient neonates without hyperbilirubinemia
Number of subjects: 2
Study: 7508070

Group type: EXPERIMENTAL
Intervention: High-dose aprotinin
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study: 1378106

Group type: EXPERIMENTAL
Intervention: Piroximone (0.5‐mg/kg bolus in 30 min and then 3‐6 micrograms/kg/min)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Enoximone (1‐mg/kg bolus and then 4‐20 micrograms/kg/min)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Dopamine (4‐10 micrograms/kg/min) and glyceroltrinitrate (0.5‐5 micrograms/kg/min)
Number of subjects: 41
Study: 624224

Group type: EXPERIMENTAL
Intervention: Betamethasone dipropionate (0.1 percent) aerosol
Number of subjects: 271
Study: 30965131

Group type: EXPERIMENTAL
Intervention: Psilocybin (315 μg/kg p.o.) during mindfulness retreat
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 38
Study: 28508427

Group type: EXPERIMENTAL
Intervention: IQP-CL-101 (two softgels twice daily before main meals)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo (matching placebo twice daily before main meals)
Number of subjects: 99
Study: 25453585

Group type: EXPERIMENTAL
Intervention: EE/GSD patch (0.55 mg ethinyl estradiol and 2.1 mg gestodene)
Number of subjects: 346

Group type: COMPARATOR
Intervention: Combined oral contraceptive (0.02 mg ethinyl estradiol and 0.1 mg levonorgestrel)
Number of subjects: 346
Study: 23602084

Group type: EXPERIMENTAL
Intervention: Viral load and CD4 cell count plus clinical monitoring (LAB)
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Combined strategy using LAB for patients starting ART with a CD4 count of 200 cells per μL or fewer
Number of subjects: 385

Group type: COMPARATOR
Intervention: Clinical monitoring (CLIN)
Number of subjects: 385
Study: 21801509

Group type: EXPERIMENTAL
Intervention: Five-element acupuncture treatment
Number of subjects: 20
Study: 19500889

Group type: EXPERIMENTAL
Intervention: Clear carbohydrate drink (CCD) (400 ml, 50 g carbohydrate, 0 g protein)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oral Nutritional Supplement (ONS400) (70 g, 50 g carbohydrate, 15 g glutamine dissolved in water to a total volume of 400 ml)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oral Nutritional Supplement (ONS300) (300 ml)
Number of subjects: 20
Study: 17657595

Group type: EXPERIMENTAL
Intervention: Low quantities (2 g) of long chain lipid
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Medium chain lipid (2 g)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Negative control formulation
Number of subjects: 16
Study: 15118480

Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg/d) and Alprazolam (1 mg/d)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Alprazolam
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Paroxetine plus Alprazolam
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Psychomotor Performance Tests and Visual Analogue Scales
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 25
Study: 10699767

Group type: EXPERIMENTAL
Intervention: Disposable biopsy forceps
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reusable biopsy forceps
Number of subjects: 0
Study: 9181527

Group type: EXPERIMENTAL
Intervention: Ribavirin (1000 mg per day) and IFN-alpha (3-6 million units thrice weekly)
Number of subjects: 48

Group type: COMPARATOR
Intervention: IFN-alpha alone
Number of subjects: 48
Study: 8475971

Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 4039146

Group type: EXPERIMENTAL
Intervention: Carbocisteine granulate (750 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Carbocisteine capsules (750 mg)
Number of subjects: 10
Study: 30810079

Group type: EXPERIMENTAL
Intervention: Swedish massage (SM)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham massage (ShM)
Number of subjects: 11
Study: 29074816

Group type: EXPERIMENTAL
Intervention: HbA1c alone
Number of subjects: 13538

Group type: EXPERIMENTAL
Intervention: Fasting laboratory tests and clinic data
Number of subjects: 13538
Study: 26896352

Group type: EXPERIMENTAL
Intervention: Qi-Wei-Qing-Yan aerosol (QWQYA) with the current propellant
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Qi-Wei-Qing-Yan aerosol (QWQYA) with a previous propellant
Number of subjects: 420

Group type: COMPARATOR
Intervention: Placebo aerosol with the current propellant
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 420
Study: 24967861

Group type: EXPERIMENTAL
Intervention: Zinc amino acid chelate
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Zinc sulfate
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 22771576

Group type: EXPERIMENTAL
Intervention: Web-based screening and accrual method using Craigslist for recruitment
Number of subjects: 77
Study: 21048706

Group type: EXPERIMENTAL
Intervention: Dipeptidyl peptidase-4 (DPP-4) inhibitor
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Combination of DPP-4 inhibitor and Metformin
Number of subjects: 2
Study: 18372687

Group type: EXPERIMENTAL
Intervention: Daily artificial gravity (AG) countermeasure treatment
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (no AG treatment)
Number of subjects: 15
Study: 16376764

Group type: EXPERIMENTAL
Intervention: Supine bicycle stress exercise
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Upright exercise treadmill testing
Number of subjects: 18

Group type: COMPARATOR
Intervention: Comparison of peak exercise treadmill testing vs peak supine bicycle stress exercise
Number of subjects: 18
Study: 11916892

Group type: EXPERIMENTAL
Intervention: Fixed power head
Number of subjects: 6

Group type: COMPARATOR
Intervention: Floating power head
Number of subjects: 6
Study: 9453690

Group type: EXPERIMENTAL
Intervention: 0.375 mg of sustained-release hyoscyamine twice a day
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 2 mg doxazosin QHS
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Combination therapy (hyoscyamine and doxazosin)
Number of subjects: 34
Study: 8575234

Group type: EXPERIMENTAL
Intervention: Perindopril 4 to 8 mg once daily
Number of subjects: 47

Group type: COMPARATOR
Intervention: Metoprolol 25 to 62.5 mg twice daily
Number of subjects: 47
Study: 2231185

Group type: EXPERIMENTAL
Intervention: Azidothymidine (AZT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 874420

Group type: EXPERIMENTAL
Intervention: Trained spoken word
Number of subjects: 8

Group type: COMPARATOR
Intervention: Untrained spoken words
Number of subjects: 8
Study: 31127269

Group type: EXPERIMENTAL
Intervention: Intravenous iron (three doses of 200 mg iron sucrose over 30 min on three separate days)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (no intravenous iron)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intravenous iron
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study: 28939890

Group type: EXPERIMENTAL
Intervention: ELF-MF treatment for 45 minutes/day
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: ELF-MF treatment for 120 minutes/day
Number of subjects: 6
Study: 25469451

Group type: EXPERIMENTAL
Intervention: Intracardiac echocardiography (ICE)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Fast anatomical mapping (FAM)
Number of subjects: 29

Group type: COMPARATOR
Intervention: MSCT (gold standard)
Number of subjects: 29
Study: 24968492

Group type: EXPERIMENTAL
Intervention: Bhastrika and Anulom Vilom Pranayam
Number of subjects: 96

Group type: COMPARATOR
Intervention: Suryanamaskar
Number of subjects: 96
Study: 21426543

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation (ORIF) with volar locked plating
Number of subjects: 504

Group type: COMPARATOR
Intervention: Closed reduction and plaster casting
Number of subjects: 504
Study: 19290712

Group type: EXPERIMENTAL
Intervention: Hypothetical cancer preventive treatment with one or two small side effects (beneficial or harmful)
Number of subjects: 5379

Group type: EXPERIMENTAL
Intervention: Presence of side effects (beneficial or harmful)
Number of subjects: 5379

Group type: COMPARATOR
Intervention: No specific intervention mentioned
Number of subjects: 5379
Study: 17235521

Group type: EXPERIMENTAL
Intervention: dTpa-IPV (Boostrix Polio)
Number of subjects: 958

Group type: COMPARATOR
Intervention: dTpa + IPV (Boostrix + IPV Mérieux)
Number of subjects: 958
Study: 15655328

Group type: EXPERIMENTAL
Intervention: On-line HDF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HDF (post, pre)
Number of subjects: 0

Group type: COMPARATOR
Intervention: HD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HDF
Number of subjects: 0
Study: 11678958

Group type: EXPERIMENTAL
Intervention: Oral administration of tacrolimus after an overnight fast
Number of subjects: 33

Group type: COMPARATOR
Intervention: Oral administration of tacrolimus 1 hour after breakfast
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Oral administration of tacrolimus after an overnight fast and 0.5 hours after breakfast (in 4 patients)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Patients who underwent continuous ambulatory peritoneal dialysis (CAPD) before transplantation
Number of subjects: 33
Study: 9039169

Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 7686471

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Low dose ethanol (LD)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: High dose ethanol (HD)
Number of subjects: 42
Study: 2881499

Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pancuronium
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Glycopyrronium
Number of subjects: 120

Group type: COMPARATOR
Intervention: Inert placebo
Number of subjects: 120
Study: 29886915

Group type: EXPERIMENTAL
Intervention: Low-dose naloxone infusion (0.5 μg/kg/h)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: High-dose naloxone infusion (2.5 μg/kg/h)
Number of subjects: 84
Study: 28049376

Group type: EXPERIMENTAL
Intervention: Cryoneuroablation
Number of subjects: 207
Study: 26364275

Group type: EXPERIMENTAL
Intervention: Huperzine A (0.4 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Huperzine A (0.8 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 24159353

Group type: EXPERIMENTAL
Intervention: Pomegranate extract (2g per day in 2 POMx pills)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (pills containing no pomegranate ingredients)
Number of subjects: 0
Study: 21245872

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 18055508

Group type: EXPERIMENTAL
Intervention: One drink of red wine
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Two drinks of red wine
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: One drink of ethanol
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Two drinks of ethanol
Number of subjects: 13
Study: 16418628

Group type: EXPERIMENTAL
Intervention: Allograft Group (37 patients)
Number of subjects: 76

Group type: COMPARATOR
Intervention: No Graft Group (39 patients)
Number of subjects: 76
Study: 12564608

Group type: EXPERIMENTAL
Intervention: Sibenadet (500 microg)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Placebo (pressurized metered-dose inhaler)
Number of subjects: 2000
Study: 10333886

Group type: EXPERIMENTAL
Intervention: Le Fort I osteotomy
Number of subjects: 15

Group type: COMPARATOR
Intervention: Mandibular advancement (control)
Number of subjects: 15
Study: 8767564

Group type: EXPERIMENTAL
Intervention: Atracurium (priming technique)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Vecuronium (priming technique)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Atracurium (bolus method)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Vecuronium (bolus method)
Number of subjects: 80
Study: 1888248

Group type: EXPERIMENTAL
Intervention: Diltiazem (sustained release) 60 to 180 mg twice a day
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Atenolol 50 to 100 mg once a day
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Enalapril 5 to 20 mg once a day
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: All three treatments
Number of subjects: 242
Study: 10255738

Group type: EXPERIMENTAL
Intervention: Education group (self-teaching booklet)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VA education participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Public health education group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combined VA and public health education group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-teaching booklet alone
Number of subjects: 0
Study: 31736433

Group type: EXPERIMENTAL
Intervention: U-Net deep learning model for tumor segmentation
Number of subjects: 502
Study: 28880931

Group type: EXPERIMENTAL
Intervention: Cardiac output goal directed therapy (GDT) algorithm
Number of subjects: 52

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 52
Study: 25471599

Group type: EXPERIMENTAL
Intervention: WHEY (whey protein solution)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: GEL (leucine-enriched whey protein gel)
Number of subjects: 9

Group type: COMPARATOR
Intervention: PLACEBO (fasted state)
Number of subjects: 9
Study: 23886255

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 55

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 55